Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model.
<h4>Purpose</h4>Melanocortin receptor 1 (MC1R) is overexpressed in melanoma and may be a molecular target for imaging and peptide receptor radionuclide therapy. 68Gallium (68Ga) labeling of DOTA-conjugated peptides is an established procedure in the clinic for use in positron emission to...
Main Authors: | Jan Lennart von Hacht, Sarah Erdmann, Lars Niederstadt, Sonal Prasad, Asja Wagener, Samantha Exner, Nicola Beindorff, Winfried Brenner, Carsten Grötzinger |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0217883 |
Similar Items
-
SPECT/CT Imaging, Biodistribution and Radiation Dosimetry of a 177Lu-DOTA-Integrin αvβ6 Cystine Knot Peptide in a Pancreatic Cancer Xenograft Model
by: Sachindra Sachindra, et al.
Published: (2021-05-01) -
Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft Models
by: Libo Zhang, et al.
Published: (2017-01-01) -
Preparation and biological studies of 68Ga-DOTA-alendronate
by: Ashraf Fakhari, et al.
Published: (2016-07-01) -
Initial clinical experience with 68Ga-DOTA-NOC prepared using 68Ga from nanoceria-polyacrylonitrile composite sorbent-based 68Ge/68Ga generator and freeze-dried DOTA-NOC kits
by: Piyush Chandra, et al.
Published: (2017-01-01) -
Standardized image quality for 68Ga-DOTA-TATE PET/CT
by: Christina P. W. Cox, et al.
Published: (2020-03-01)